Difference between revisions of "DZI20-199-Case-8"

From MGH Learn Pathology
(Updating subject, access, and performer)
(Added status template)
 
Line 74: Line 74:
 
|subject=Z0FBQUFBQmYxUVFZRC0yN2VOdnlfWFItSXhIdEJxU3V3X3lQZFVZcG9FMGNfNUp3bXByQ0w0NmpxME5KZk1VUWU2Y09mejFXWUp2SUFKdXV5WTFHNWhRRzRTaVJlREtlVEE9PQ
 
|subject=Z0FBQUFBQmYxUVFZRC0yN2VOdnlfWFItSXhIdEJxU3V3X3lQZFVZcG9FMGNfNUp3bXByQ0w0NmpxME5KZk1VUWU2Y09mejFXWUp2SUFKdXV5WTFHNWhRRzRTaVJlREtlVEE9PQ
 
|modality=mrxs
 
|modality=mrxs
 +
}}
 +
{{status
 +
|status=active
 +
|requester=Mjf79
 +
|authoredOn=December 12, 2020 05:49:40 PM
 
}}
 
}}

Latest revision as of 14:00, December 9, 2024

DZI20-199-Case-8
pancreas mass - whipple

FX2: bile duct margin FX4 + level: Pancreas transection margin

FX5: thickened common bile duct
FX2 (bile duct margin): TINEM

FX4 (pancreatic transection margin): Small ducts with involvement by intramucosal malignancy, at least high-grade dysplasia (permanent: invasive adenocarcinoma, moderately differentiated)

FX5 (thickened common bile duct): Invasive adenocarcinoma (permanent: invasive adenocarcinoma, moderately differentiated - pancreatic head origin, possibility of bile duct considered by favored against)
December 31, 1969 7:00:00 PM